The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 358:95 January 3, 2008 Number 1
NextNext

Uremia

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Meyer, T. W.
-PubMed Citation
To the Editor: In their review of uremia, Meyer and Hostetter (Sept. 27 issue)1 mention that cellular functions can be disordered in uremia, and as an example, they cite inhibition of sodium–potassium ATPase by retained digitalis-like substances such as marinobufagenin. However, they do not discuss the significance of sodium–potassium pump inhibition. One effect of sodium–potassium pump inhibition in some cells is depolarization of the membrane potential due to unequal transfer of sodium and potassium across cell membranes by the pump, which can affect the function of many types of cells. In vascular smooth muscle, the effect is influx of calcium . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.